Bridgeway Capital Management’s Covisint Corporation COVS Stock Holding History

Bridgeway Capital Management’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-187,200	Closed	-$459K	–	1500
2017 Q2	$459K	Hold	187,200	–	–	0.01%	1114
2017 Q1	$384K	Hold	187,200	–	–	﹤0.01%	1143
2016 Q4	$356K	Hold	187,200	–	–	﹤0.01%	1189
2016 Q3	$408K	Sell	187,200 -18,900	-9%	-$41.3K	0.01%	1159
2016 Q2	$449K	Hold	206,100	–	–	0.01%	1092
2016 Q1	$412K	Hold	206,100	–	–	0.01%	1124
2015 Q4	$515K	Buy	206,100 +115,500	+127%	+$261K	0.01%	1050
2015 Q3	$195K	Hold	90,600	–	–	﹤0.01%	1316
2015 Q2	$296K	Sell	90,600 -19,400	-18%	-$46K	0.01%	1254
2015 Q1	$223K	Hold	110,000	–	–	﹤0.01%	1312
2014 Q4	$292K	Buy	+110,000	New	+$315K	0.01%	1229

Bridgeway Capital Management's COVS Position: Q3 2017 in Review

Bridgeway Capital Management sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 187,200 shares — an estimated $459K sold.

Bridgeway Capital Management first reported a position in COVS in Q4 2014 and held it in 11 quarters. The position peaked at $515K in Q4 2015. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

Bridgeway Capital Management reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
Bridgeway Capital Management sold 187,200 Covisint Corporation shares in Q3 2017, an estimated $459K.
Bridgeway Capital Management first reported a position in Covisint Corporation in Q4 2014 and held it in 11 quarters.
Bridgeway Capital Management's Covisint Corporation position peaked at $515K in Q4 2015.
0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on Bridgeway Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.